Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 1.00 |
| ▸ | SLC28A2 | O43868 | 1/20 | 1.00 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 1.00 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 1.00 |
| ▸ | P2RY2 | P41231 | 11/20 | 0.69 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.65 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.63 |
| ▸ | P2RY14 | Q15391 | 7/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uridine SCHEMBL14853938 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL2056533 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL329746 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL10815678 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL2056827 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL9060684 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL375985 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Arauridine SCHEMBL359587 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL20987631 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL1804774 | 1.00 | SLC28A1 (1.00) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6242428-B1 | NUCLEOSIDES AND NUCLEOSIDE DIMERS CONTAINING AN L-SUGAR IN AT LEAST ONE OF THE NUCLEOSIDES | UNISEARCH LIMITED (AU) | 2001-06-05 | — | — | US | disclosed |
| US-6207649-B1 | DINUCLEOSIDE DIMERS AND DERIVATIVES INCLUDING L-DEOXYRIBOFURANOSYL NUCLEOSIDE PHOSPHODIESTER DIMERS IN WHICH SUGAR MOIETY OF ONE OF THE NUCLEOSIDES HAS AN L-CONFIGURATION; TREATMENT OF BACTERIAL, VIRAL, AND FUNGAL INFECTIONS, CANCER | LIPITEK INTERNATIONAL, INC. | 2001-03-27 | — | — | US | disclosed |
| EP-1069903-A1 | NOVEL NUCLEOSIDE ANALOGS AND USES IN TREATING DISEASE | Lipitek International, Inc. (US) | 2001-01-24 | — | — | EP | disclosed |
| US-6025335-A | L-DEOXYRIBOFURANOSYL NUCLEOSIDE PHOSPHODIESTER DIMERS WHERE THE SUGAR MOIETY OR AT LEAST ONE OF THE NUCLEOSIDES HAS AN L-CONFIGURATION, CANCER AND VIRAL INFECTIONS, IN MAMMALS. | LIPITEK INTERNATIONAL, INC. (US) | 2000-02-15 | — | — | US | disclosed |
| WO-1999045935-A1 | NOVEL NUCLEOSIDE ANALOGS AND USES IN TREATING DISEASE | LIPITEK INTERNATIONAL, INC. (US) | 1999-09-16 | — | — | WO | disclosed |
| US-5939402-A | TREATING PLASMODIUM, VIRAL INFECTIONS OR PARASITES IN MAMMALS | LIPITEK INTERNATIONAL, INC. (US) | 1999-08-17 | — | — | US | disclosed |
| EP-0793669-A4 | L-NUCLEOSIDE DIMER COMPOUNDS AND THERAPEUTIC USES | LIPITEK INTERNATIONAL INC (US) | 1999-02-03 | — | — | EP | disclosed |
| EP-0793669-A1 | L-NUCLEOSIDE DIMER COMPOUNDS AND THERAPEUTIC USES | Lipitek International, Inc. (US) | 1997-09-10 | — | — | EP | disclosed |
| WO-1997011087-A1 | L-NUCLEOSIDE DIMER COMPOUNDS AND THERAPEUTIC USES | LIPITEK INTERNATIONAL, INC. (US) | 1997-03-27 | — | — | WO | disclosed |